Company
Typewriter Therapeutics
Authoring a new chapter in durable genetic medicines for patients living with cancer and other life-threatening diseases.
Also known as Typewriter Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2022
- typewritertx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Typewriter is building genetic medicines with the potential for durable, curative impact on patients with cancer, autoimmune and severe genetic diseases
Funding snapshot
- Total raised
- $56MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $56M2026-09-02
Funding rounds
- Series A
- $56M2026-09-02, Company stated
Loading relationship preview